Trials / Conditions / Oral Cavity Carcinoma

Oral Cavity Carcinoma

14 registered clinical trials studyying Oral Cavity Carcinoma — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Intratumoral Delivery of Viral Replicon (saRNA) Particles Expressing IL-12 in Head and Neck Cancer NCT06736379	VLP Therapeutics	Phase 1
Recruiting	Flap Sparing in Postoperative Radiotherapy of Oral Cavity Cancers NCT06798922	Centre Francois Baclesse	Phase 3
Recruiting	Role of Acetaldehyde in the Development of Oral Cancer NCT05973656	Masonic Cancer Center, University of Minnesota	N/A
Terminated	Metformin for the Prevention of Oral Cancer in Patients With Oral Premalignant Lesions NCT05536037	Thomas Jefferson University	Phase 1
Active Not Recruiting	Intensity Modulated Proton or X-Ray Therapy After Surgery for Treatment of Head and Neck Cancer, the HEADLIGHT NCT05075980	Mayo Clinic	Phase 2
Recruiting	Customized 3D Printed Oral Stents During Head and Neck Radiotherapy NCT04870762	M.D. Anderson Cancer Center	Phase 2
Completed	Exercise Training and Behavioral Modification for the Improvement of Physical Activity in Head and Neck Cancer NCT04788264	Thomas Jefferson University	N/A
Terminated	Celecoxib Through Surgery and Radiation Therapy for the Treatment of Advanced Head and Neck Cancer NCT04162873	University of Utah	Phase 2
Completed	Pembrolizumab in Treating Patients With High Risk Oral Intraepithelial Neoplasia NCT02882282	M.D. Anderson Cancer Center	Phase 2
Active Not Recruiting	Nivolumab and Ipilimumab in Treating Patients With Rare Tumors NCT02834013	National Cancer Institute (NCI)	Phase 2
Active Not Recruiting	Metformin Hydrochloride in Preventing Oral Cancer in Patients With an Oral Premalignant Lesion NCT02581137	National Cancer Institute (NCI)	Phase 2
Completed	Behavior Changing Intervention for Smokeless Tobacco and Betel Quid Use in Adolescents NCT03488095	Dow University of Health Sciences	N/A
Active Not Recruiting	Extended Follow Up of Young Women in Costa Rica Who Received Vaccine for Human Papillomavirus Types 16 and 18 NCT00867464	National Cancer Institute (NCI)	—
Completed	Physiotherapy Treatment for Patients Suffering From Head and Neck Cancer NCT00780312	Rigshospitalet, Denmark	Phase 2